Ji 2025 — Ecnoglutide for Overweight or Obesity

The Lancet Diabetes & Endocrinology

Linong Ji, et al.

Summary

Once-weekly ecnoglutide was studied for body-weight reduction in Chinese adults with overweight or obesity.

Study Details

Study Design

Randomized double-blind placebo-controlled trial

Indication

Overweight or obesity

Intervention

Once-weekly ecnoglutide vs placebo

Species

Human

Risk of Bias Assessment

Sponsor-funded